Declines in drug fatalities are clear public health benefits. However, there is much more work to be done to address drug mortality, including addressing increases in polysubstance use involving ...

Supply chain disruptions may drive a return of dangerous clandestine drug labs across the U.S., increasing health and safety risks for officers and first responders. The decline in international drug ...

In March, officials with the N.C. Department of Health and Human Services announced a $1.5 million expansion of LEAD programs ...

Public health and addiction experts fear millions could lose access to treatment and prevention services if the administration’s proposed cuts are enacted. By Jan Hoffman President Trump has long ...

Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy Many drugs in development continue to follow the historical drug development ...